Freebase is currently in read-only mode

Topic

Created by fda_medical_bot on 1/7/2012

300 film coated tablet ^en

mid: /m/0hqv7kd notable type: /medicine/drug_formulation notable for: /medicine/drug_formulation

Efavirenz, emtricitabine, and tenofovir disoproxil fumarate film coated tablet, for oral administration, consisting of: 600mg/tablet efavirenz ; 200mg/tablet emtricitabine ; 300mg/tablet tenofovir disoproxil fumarate.Indications:ATRIPLA, a combination of 2 nucleoside analog HIV-1 reverse transcriptase inhibitors and 1 non-nucleoside HIV-1 reverse transcriptase inhibitor, is indicated for use alone as a complete regimen or in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults. (1) [ - ]

Types:

Add type

Metaweb System Types

Object

Common

Topic

Medicine

Drug formulation

Freebase

Object profile

Object is not asserted on this topic.

ID /type/object/id

GUID /type/object/guid

#9202a8c04000641f800000001f6d1e2c

Type /type/object/type

Drug formulation
Topic

Name /type/object/name

- - Edit
  - Delete
Efavirenz, emtricitabine, and tenofovir disoproxil fumarate 600/200/300 film coated tablet

Key /type/object/key

- - Edit
  - Delete
/base/medicaldrugs/fda_load/form_JE6H2O27P8_600_0mg_tablet_G70B4ETF4S_200_0mg_tablet_OTT9J7900I_300_0mg_tablet_film_coated_tablet_oral

Timestamp /type/object/timestamp

Saturday, January 07, 2012 8:52 AM

Permission /type/object/permission

/boot/all_permission

Creator /type/object/creator

fda_medical_bot

Attribution /type/object/attribution

fda_medical_bot

Search /type/object/search

Machine ID /type/object/mid

/m/0hqv7kd

Also known as /common/topic/alias

Description /common/topic/description

- - Edit
  - Delete
Efavirenz, emtricitabine, and tenofovir disoproxil fumarate film coated tablet, for oral administration, consisting of: 600mg/tablet efavirenz ; 200mg/tablet emtricitabine ; 300mg/tablet tenofovir disoproxil fumarate.Indications:ATRIPLA, a combination of 2 nucleoside analog HIV-1 reverse transcriptase inhibitors and 1 non-nucleoside HIV-1 reverse transcriptase inhibitor, is indicated for use alone as a complete regimen or in combination with other antiretroviral agents for the treatment of HIV-1 infection in adults. (1)

Image /common/topic/image

Official website /common/topic/official_website

Topic equivalent webpage /common/topic/topic_equivalent_webpage

Social media presence /common/topic/social_media_presence

Topical webpage /common/topic/topical_webpage

Subjects /common/topic/subjects

Subject of /common/topic/subject_of

Web Link(s) (deprecated) /common/topic/webpage

-

Properties /common/topic/properties

Article /common/topic/article

<p>Efavirenz, emtricitabine, and tenofovir disoproxil fumarate film coated tablet, for oral...

Weblink /common/topic/weblink

Notable for /common/topic/notable_for

Drug formulation

Notable types /common/topic/notable_types

Drug formulation

Active ingredients /medicine/drug_formulation/active_ingredients

Strength /medicine/drug_formulation/strength

Strength value	Strength units	Active ingredient	Drug formulations available in this strength
Edit Delete View CVT 200.00	mg/tablet	Emtricitabine	-
Edit Delete View CVT 600.00	mg/tablet	Efavirenz	-
Edit Delete View CVT 300.00	mg/tablet	Tenofovir Disoproxil Fumarate	-